Insider holders · CIK 0001636651
Ovid Therapeutics Inc. · OVID
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Jeremy M LevinCEO | 4,676,529 | 465,116 | 5,141,645 | Feb 26, 2019 · 9:42 pm EST | Form 4 |
| Matthew DuringPresident and CSO | 4,307,314 | 93,023 | 4,400,337 | May 10, 2017 · 5:14 pm EDT | Form 4 |
| Charles Ross CarterChief Financial Officer | 94,375 | — | 94,375 | Jul 8, 2026 · 4:31 pm EDT | Form 4 |
| Karen BernsteinDirector | 20,000 | — | 20,000 | Feb 28, 2019 · 8:15 pm EST | Form 4 |
| Douglas E WilliamsDirector | 5,000 | — | 5,000 | Aug 16, 2018 · 9:22 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.